2015 - November 20th - "Identifying hereditary pancreatic and gastric cancer predisposition using the CCGCRN"

  • Register
    • Non-Member - $25
    • COH Staff - Free!
    • IC Faculty - Free!
    • IC Student - Free!
    • CCGCOP - Free!
    • CCGCRN - Free!
    • CCGCRN-Latin America - Free!
    • LiFE - Free!
    • KGI 2019 - Free!

"Identifying hereditary pancreatic and gastric cancer predisposition using the CCGCRN cohort" presented on November 20th, 2015 by Thomas Slavin, MD during City of Hope's Division of Clinical Cancer Genetics Community of Practice Weekly Topics in Cancer Genetics Research (TICGR).

Thomas Slavin, MD, FACMG, DABMD

Senior Vice President of Medical Affairs for Oncology

Myriad Genetics

Dr. Slavin is Senior Vice President of Medical Affairs for Oncology at Myriad Genetics. He is a physician-scientist, triple-board-certified in clinical genetics, molecular diagnostics and pediatrics. Most recently, he served as assistant professor in the departments of Medical Oncology & Therapeutics Research and Population Sciences at City of Hope National Medical Center. Dr. Slavin graduated medical school with Alpha-Omega-Alpha-honors from the University of South Florida. He completed his residency programs at Case Western Reserve in Cleveland, Ohio; this training included a postdoctoral research year in genetic epidemiology. He has also completed graduate course work towards a Masters degree in clinical research through the University of Southern California. He is an active member of the American Association of Cancer Research, the American Society of Clinical Oncology (ASCO), the American Society of Human Genetics, the Collaborative Group of the Americas on Inherited Colorectal Cancer, and is a fellow of the American College of Medical Genetics and Genomics. He has served on National Comprehensive Cancer Network (NCCN)committees for both the genetics of and screening for colorectal cancer. He has served on three ClinGen expert working group committees for variant classification of breast, gastrointestinal and ovarian cancer predisposition genes. Focused on expanding genetics education for cancer care providers, Dr. Slavin has helped shape both ASCO University as well as City of Hope’s hereditary genomics training program. He is a well-published researcher in the field of medical genetics, including over 60 journal articles, multiple book chapters, and numerous presentations at national and international medical meetings. He has been involved in many national cancer research grants, and was a 2018 National Institutes of Health (NIH) K08-career development grant awardee.

Components visible upon registration.